Side effects Dosage information During pregnancy FDA approval history Drug class: miscellaneous coagulation modifiers En español Patient resources Roctavian drug information Professional resources Valoctocogene Roxaparvovec monograph Related treatment guides Hemophilia A Medical...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that an individual in Germany with severe hemophilia A was treated with ROCTAVIAN® (valoctocogene roxaparvovec-rvox), marking the first time that the gene therapy has been ...